✦ LIBER ✦

Single-agent versus combination chemotherapy in advanced non-small cell lung cancer (NSCLC): A CALGB randomized trial of efficacy, quality of life, and cost-effectiveness

✍ Scribed by R. Lilenbaum; J. Herndon; M. List; C. Desch; D. Watson; J. Holland; J. Weeks; M. Green

Book ID: 117658417
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 328 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81051-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination versus sequential single-age

Combination versus sequential single-agent chemotherapy in the treatment of patients with advanced non-small cell lung cancer

✍ Niell, Harvey B. ;Griffin, John P. ;Hunter, Robert F. ;Meredith, Charlotte A. ;S 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

We have carried out a randomized phase Ill study in 105 patients with advanced nonsmall cell lung cancer, comparing a fourdrug cisplatin-mitomycin-based combination chemotherapy regimen t o sequential single-agent therapy. The combination chemotherapy regimen consisted of mitomycin C (10 mg/m2), vin

PCN96 A TRIAL-BASED ASSESSMENT OF THE CO

PCN96 A TRIAL-BASED ASSESSMENT OF THE COST-UTILITY OF BEVACIZUMAB AND CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

✍ B Goulart; S Ramsey 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Patterns, costs and cost-effectiveness o

Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer

✍ Billingham, L.J; Bathers, S; Burton, A; Bryan, S; Cullen, M.H 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Efficacy and Safety of Single-Agent Axit

Efficacy and Safety of Single-Agent Axitinib (AG-013736; AG) in Patients with Advanced Non–Small-Cell Lung Cancer (NSCLC): A Phase II Trial

✍ J.H. Schiller; J. von Pawel; T. Larson; S.I. Ou; S.A. Limentani; A.B. Sandler; E 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 442 KB

Platinum-based combination chemotherapy

Platinum-based combination chemotherapy in advanced non-small cell lung cancer: A randomized phase II trial of the cancer and leukemia group B

✍ Green, Mark R. ;Kramar, Andrew ;Schilsky, Richard ;Stoopler, Marc ;Zimmer, Bonni 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

## Abstract The Cancer and Leukemia Group B (CALGB) utilized a randomized phase II trial design to evaluate two cisplatin‐based combinations, cisplatin‐cytarabine (ara‐C) and cisplatin‐vinblastine, in 151 patients with advanced non‐small cell lung cancer. Patients entered on study had not received

Initial comparative study on the efficac

Initial comparative study on the efficacy of single agent gemcitabine versus combination gemcitabine and cisplatin in Filipino patients with advanced non-small cell lung cancer

✍ Gorospe, A; Cristal-Luna, G; Li, R; Garcia, J; Roces, L; Lola, C; Matunog, C; Ma 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB